News & Press

March 18, 2019 | PR Newswire

miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer
October 4, 2018 | WUOF

miR Scientific Presents at 2018 World Urological Oncology Federation Conference
October 4, 2018 | WUOF

miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer
July 20, 2018 | GenomeWeb

miR Scientific to Present Novel Array Technologies for Diagnosis and Prognosis of Urogenital Cancers at the 2018 ASCO Annual Meeting
October 4, 2018 | PR Newswire

MiR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data
July 9, 2018 | PR Newswire

miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer
July 4, 2018 | FOIUS

The 4th Friends of Israel Urological Symposium
June 6, 2018 | PR Newswire

miR Scientific to Present Novel Array Technologies for Diagnosis and Prognosis of Urogenital Cancers at the 2018 ASCO Annual Meeting
June 6, 2018 | miR Scientific

Novel Platform for Bladder Cancer Detection using Expression Analysis of Small Non-coding RNAs
June 6, 2018 | ASCO

Validation of a new diagnostic platform for prostate cancer using expression proling of small non-coding RNAs
June 6, 2018 | ASCO

Novel platform for monitoring bladder cancer recurrence using expression analysis of small non-coding RNAs
June 11, 2015 | GenomeWeb

MiR Diagnostics Advances Non-Coding RNA Test for Prostate Cancer Classification